CD57 Antikörper
Kurzübersicht für CD57 Antikörper (ABIN6296495)
Target
Alle CD57 (B3GAT1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Mouse anti-Human CD57 Antibody [Sodium Azide Free]
-
Spezifität
- Cell surface, cytoplasmic
-
Aufreinigung
- Human peripheral blood mononuclear cells were used as the immunogen for the anti-CD57 antibody.
-
Immunogen
- Human peripheral blood mononuclear cells were used as the immunogen for the anti-CD57 antibody.
-
-
-
-
Applikationshinweise
-
Immunofluorescence: 0.5-1 μg/mL
Immunohistochemistry (FFPE): 2-4 μg/mL for 30 min at RT (1)
Prediluted format: incubate for 30 min at RT (2) -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- CD57 (B3GAT1) (beta-1,3-Glucuronyltransferase 1 (Glucuronosyltransferase P) (B3GAT1))
-
Andere Bezeichnung
- Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1
-
Hintergrund
-
Target Description: Anti-CD57 marks a subset of lymphocytes known as natural killer (NK) cells. Follicular center cell lymphomas often contain many NK cells within the neoplastic follicles. Anti-CD57 also stains neuroendocrine cells and their derived tumors, including carcinoid tumor and medulloblastoma. Anti-CD57 can also be useful in separating type B3 thymoma from thymic carcinoma when combined with a panel that includes antibodies against GLUT1, CD5, and CEA.
Gene Symbol: B3GAT1///GLCATP
-
Gen-ID
- 27087
-
UniProt
- Q9P2W7
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-